Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 4169-4171, September 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lan, M. S.
Right arrow Articles by Notkins, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lan, M. S.
Right arrow Articles by Notkins, A. L.

IA-1, a New Marker for Neuroendocrine Differentiation in Human Lung Cancer Cell Lines

Michael S. Lan1, Edward K. Russell, Jia Lu, Bruce E. Johnson and Abner Louis Notkins

Laboratory of Oral Medicine, National Institute of Dental Research [M. S. L., J. L., A. L. N.], NIH, Bethesda 20892, and National Cancer Institute-Navy Oncology Branch, National Naval Medical Center [E. K. R., B. E. J.], Bethesda, Maryland 20889-5105

IA-1 is a recently isolated novel complementary DNA which encodes a protein of 510 amino acids that contains both a zinc finger DNA-binding domain and a putative prohormone domain. mRNA expression of IA-1 has been found thus far only in tumors of neuroendocrine origin. In this report we describe the expression of IA-1 mRNA in a panel of 64 human lung cancer cell lines. IA-1 mRNA was detected by Northern blot analysis in 97% (30 of 31) of small cell lung cancer cell lines. In contrast, IA-1 mRNA was detected in only 13% (4 of 30) of non-small cell lung cancer cell lines. Nine of the 30 (30%) expressed either chromogranin A mRNA or produced L-dopa decarboxylase. Four of these 9 (44%) had detectable levels of IA-1 mRNA. In most of the lung cancer cell lines examined, IA-1 showed high concordance with the other neuroendocrine markers, L-dopa decarboxylase, and chromogranin A. The one exception was a variant small cell lung cancer cell line which expressed low or nondetectable levels of L-dopa decarboxylase. IA-1 is a candidate marker of neuroendocrine differentiation of human lung tumors.

1 To whom requests for reprints should be addressed, at Laboratory of Oral Medicine, National Institute of Dental Research, NIH, Building 30, Room 121, Bethesda, MD 20892.

Received 7/ 7/93. Accepted 8/ 3/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. M. Myers and L. M. Mulligan
The RET Receptor Is Linked to Stress Response Pathways
Cancer Res., July 1, 2004; 64(13): 4453 - 4463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Breslin, M. Zhu, and M. S. Lan
NeuroD1/E47 Regulates the E-box Element of a Novel Zinc Finger Transcription Factor, IA-1, in Developing Nervous System
J. Biol. Chem., October 3, 2003; 278(40): 38991 - 38997.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sugita, M. Geraci, B. Gao, R. L. Powell, F. R. Hirsch, G. Johnson, R. Lapadat, E. Gabrielson, R. Bremnes, P. A. Bunn, et al.
Combined Use of Oligonucleotide and Tissue Microarrays Identifies Cancer/Testis Antigens as Biomarkers in Lung Carcinoma
Cancer Res., July 15, 2002; 62(14): 3971 - 3979.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. B. Breslin, M. Zhu, A. L. Notkins, and M. S. Lan
Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence
Nucleic Acids Res., February 15, 2002; 30(4): 1038 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wu, A. Duggan, and M. Chalfie
Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans
Genes & Dev., March 15, 2001; 15(6): 789 - 802.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Tateno, Y. Fukunishi, S. Komatsu, Y. Okazaki, J. Kawai, K. Shibata, M. Itoh, M. Muramatsu, W. A. Held, and Y. Hayashizaki
Identification of a Novel Member of the Snail/Gfi-1 Repressor Family, mlt 1, Which Is Methylated and Silenced in Liver Tumors of SV40 T Antigen Transgenic Mice
Cancer Res., February 1, 2001; 61(3): 1144 - 1153.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
B. Tong, H. L. Grimes, T.-Y. Yang, S. E. Bear, Z. Qin, K. Du, W. S. El-Deiry, and P. N. Tsichlis
The Gfi-1B Proto-Oncoprotein Represses p21WAF1 and Inhibits Myeloid Cell Differentiation
Mol. Cell. Biol., May 1, 1998; 18(5): 2462 - 2473.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bhattacharjee, W. G. Richards, J. Staunton, C. Li, S. Monti, P. Vasa, C. Ladd, J. Beheshti, R. Bueno, M. Gillette, et al.
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
PNAS, November 20, 2001; 98(24): 13790 - 13795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.